Johnson & Johnson SEC filings JNJ
Johnson & Johnson has 1,000 filings in SEC EDGAR's recent list, going back to Aug 2, 2018. Its latest annual report, Form ARS, was filed on Mar 11, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Feb 11, 2026 | — |
| 424B2 | Prospectus | Feb 21, 2025 | — |
| 424B2 | Prospectus | Feb 19, 2025 | — |
| FWP | Free writing prospectus | Feb 19, 2025 | — |
| 424B5 | Prospectus supplement | Feb 19, 2025 | — |
| FWP | Free writing prospectus | Feb 18, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| 424B2 | Prospectus | May 16, 2024 | — |
| 424B2 | Prospectus | May 15, 2024 | — |
| FWP | Free writing prospectus | May 14, 2024 | — |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| FWP | Free writing prospectus | May 14, 2024 | — |
| 424B5 | Prospectus supplement | May 13, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 16, 2023 | — |
| S-8 | Employee stock plan registration | Apr 29, 2022 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| S-8 POS | Filing | Dec 21, 2020 | — |
| 424B2 | Prospectus | Aug 24, 2020 | — |
| FWP | Free writing prospectus | Aug 20, 2020 | — |
| 424B5 | Prospectus supplement | Aug 20, 2020 | — |
| S-3ASR | Automatic shelf registration | Feb 18, 2020 | — |
| S-8 POS | Filing | Jun 25, 2019 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JNJ (NYSE)
- Fiscal year ends
- January 3
- Incorporated in
- NJ
- Headquarters
- New Brunswick, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 200406
- Former names
- JOHNSON & JOHNSON ET AL (until Jan 23, 1996)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.